News

Deal-minded Venn buys another CRO

CRO Venn Life Sciences is spreading its reach around Europe through M&A, buying up a French outsourcer to bolster its abilities in data management.

Icon charts another sales jump with eyes on a big year

CRO giant Icon continued its steady progress with another double-digit quarter of sales growth, piling up revenue with hopes of clearing $1.5 billion this year.

Charles River's checkbook fuels a leap in revenue

Charles River Laboratories is dialing up its expectations for the year after some M&A padded its second-quarter results, riding a 16.5% boost in sales.

Quintiles and Roche take to China with testing partnership

Quintiles has signed a deal with a Roche diagnostics subsidiary to offer cancer screenings in China, looking to capitalize on the growing market for clinical trials in the country.

Parexel notches double-digit annual growth with a big year ahead

Parexel International posted an 11.8% revenue increase in its just-concluded fiscal year, posting record sales and forecasting another banner year.

Genae's expansion binge brings it a U.K. foothold

Belgian medical device CRO Genae has landed in London, giving the fast-growing company a presence in the U.K. as it stretches its reach across Europe.

Pfizer and Roche join Icon's adaptive-trial alliance

Pfizer and Roche are the latest pharma heavyweights to join Icon's consortium of drugmakers working to flesh out new technology for adaptive clinical trials, allowing study sponsors to react to results in real time and maximize efficacy.

Columbia Labs partners up for preclinical services

Columbia Laboratories has struck a deal with CRO XenoGesis to team up on preclinical research, pooling their resources to offer tandem early-phase services.

Covance dials up revenue but dims its full-year outlook

Covance posted a strong revenue performance in the second quarter thanks to better-than-expected results from its early-stage development segment, but the CRO is inching back its full-year expectations to account for some outgoing assets.

Quintiles ratchets up its expectations after a record quarter

Quintiles hit the $1 billion revenue mark for a third straight quarter, dialing up its full-year guidance as it expands its share of the global outsourcing market.

Catalent hauls in $871.3M in a supersized IPO

Catalent came through with the biggest life sciences IPO of what's shaping up to be a record year, pulling in $871.3 million in a blockbuster Wall Street debut.

Otsuka, Horizon team up on early-stage development

Horizon Discovery, which makes its money providing development expertise to drugmakers, has signed a deal with Otsuka Pharmaceutical to apply its technology to some early-phase treatments.

Contractor ABL snags an immune-focused CRO

Maryland's ABL has struck a deal to buy a majority stake in Platine Pharma Services, a French contract R&D organization that specializes in substances that provoke an immune response.

Icon will teach Cambridge students how to market drugs

Global CRO Icon has deepened its longstanding relationship with Cambridge University, agreeing to lead a class on pricing and market access for new drugs.

TransCelerate taps Cognizant to get its Big Pharma backers on the same page

TransCelerate BioPharma, a nonprofit run by 19 of the world's largest drugmakers, formed two years ago to help Big Pharma share resources and stop wasting time and money on noncompetitive work. Now, the group is looking to create a novel platform to standardize how clinical trial sites communicate with sponsors, choosing contractor Cognizant to develop it.

SRI's in-house CRO inks a $49M deal with NIH

The CRO unit of nonprofit researcher SRI International has paired up with NIH's National Institute of Allergy and Infectious Diseases, signing a $49 million contract to handle preclinical work on potential treatments for HIV.

Basilea picks Quintiles to move its antibiotic in Europe

Basilea Pharmaceutica ran into an FDA roadblock in its efforts to commercialize a new antibiotic, but the Swiss drug developer already has a green light in Europe, and it's tapping Quintiles' global marketing expertise to launch the treatment on its home continent.

CRO Accovion rolls into Italy with eyes on France

German-headquartered CRO Accovion is expanding its reach in Europe, opening a new shop in Italy and planning to launch a French subsidiary in the fall.

Amid global expansion, India's GVK focuses on clinical development

Indian CRO GVK Biosciences has spent the last year transitioning from a discovery-focused contractor to a full-service developer, now launching a dedicated clinical research unit to reach drugmakers around the world.

Theorem eyes an Indian expansion with latest partnership

CRO Theorem Clinical Research has inked a deal with India's Excel Life Sciences to broaden its footprint in the country, expanding its access to clinical trial sites and bolstering its patient-recruitment capabilities.